Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
Version 5 of 10 (2007-09-04 to 2008-04-08) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
Solvay Pharma Inc.
102 - 60 Columbia Way Markham, ON L3R 0C9 Canada |
Telephone number: | 905-944-2480 Ext.: 203 |
Fax number: | 905-944-2481 |
Responsible officer name and position during the period of this registration: | Graham Jobson, President & CEO |
Description of activities: | The provision of innovative pharmaceutical products to the Canadian market |
The client is a subsidiary of the following parent companies: |
Solvay S.A.
rue du Prince Albert 33 B-1050 Brussels Belgium |
Coalition | The corporation is not a member of a coalition. |
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
Name: | Jim Smyth |
Position title: | Manager, Corporate Affairs |
Public offices held: | No |
Name: | Sean Webster |
Position title: | Vice President, Corporate Affairs |
Public offices held: | Yes |
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Health Canada (HC), Industry Canada, Members of the House of Commons, National Defence (DND), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC) | ||||||||
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||
Subject Matter: Areas of Concern: | Aboriginal Affairs, Defence, Government Procurement, Health, Industry, Intellectual Property, Science and Technology | ||||||||
Subject Matter: Retrospective: | Discussions with government officials regarding the listing of innovative drug products on various federal government drug formularies. | ||||||||
Subject Matter: Prospective: | Discussions with federal officials regarding the listing of innovative drug products on various federal government drug formularies. | ||||||||
Details Regarding the Identified Subject Matter
|